An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer infections, the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa heard last month. Some additional analyses suggested a higher level of effectiveness. Moreover, African women who took part in the study told researchers that they liked the product, found it easy to use and preferred it to possible alternatives such as tablets or vaginal gels. Read full article here.